Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Turkish Journal of Medical Sciences|October 28, 2019
Anti-interleukin-6 (tocilizumab) therapy in Takayasu's arteritis: a real life experienceLevent Kılıç, Ömer Karadağ, Abdulsamet Erden, et al.
Clinical and Experimental Rheumatology|September 10, 2019
Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registryEmre Bilgin, Bayram Farisoğulları, Berkan Armağan, et al.
Clinical and Experimental Rheumatology|February 26, 2021
Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO RegistryBayram Farisoğulları, Gözde Kübra Yardımcı, Alper Sarı, et al.
Turkish Journal of Medical Sciences|September 27, 2020
Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experienceEmre Bilgin, Furkan Ceylan, Emine Duran, et al.
Turkish Journal of Medical Sciences|July 21, 2023
Pulmonary hypertension in Behçet's disease: echocardiographic screening and multidisciplinary approachBerkan Armağan, Metin Okşul, Yusuf Ziya Şener, et al.
Clinical and Experimental Rheumatology|November 13, 2018
Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?Abdulsamet Erden, Ezgi Deniz Batu, Alper Sarı, et al.
Rheumatology International|November 22, 2014
Retro-orbital granuloma associated with granulomatosis with polyangiitis: a series of nine casesBerivan Bitik, Levent Kılıç, Orhan Küçükşahin, et al.
Turkish Journal of Medical Sciences|November 21, 2017
The clinical features and outcomes of Turkish patients with IgG4-related disease:a single-center experienceÖmer Karadağ, Abdulsamet Erden, Emine Arzu Ayhan, et al.
Upsala Journal of Medical Sciences|January 25, 2018
Increased psoriasis frequency in patients with familial Mediterranean feverAbdulsamet Erden, Ezgi Deniz Batu, Emrah Seyhoğlu, et al.
Pageof 12